Home › Companies › MYRIAD GENETICS INC. › 2024-2025

MYRIAD GENETICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and MYRIAD GENETICS INC.’s Form 8-K, filed 2025-06-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.

8Reported items
250Asset managers
1,743Fund votes
2025-06-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore MYRIAD GENETICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by MYRIAD GENETICS INC.

These tallies are MYRIAD GENETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

MYRIAD GENETICS INC. — official shareholder meeting results, meeting held 2025-06-05
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Samraat S. Raha	73,401,449	258,083	23,526	--	8,547,127	Majority: yes
Elect Director: Heiner Dreismann, PH.D.	69,560,417	4,098,163	24,478	--	8,547,127	Majority: yes
Elect Director: Colleen F. Reitan	69,922,952	3,732,650	27,456	--	8,547,127	Majority: yes
Proposal 2: Ratification of the Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025	78,614,062	3,591,463	24,660	--	--	Majority: yes
Proposal 3: Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers, as Disclosed in the Proxy Statement	67,755,156	5,847,659	80,243	--	8,547,127	Majority: yes
Proposal 4: Approval of a Proposed Amendment to the 2017 Plan to Replenish the Share Pool for Equity Incentive Grants	69,476,724	4,175,785	30,549	--	8,547,127	Majority: yes

Source: MYRIAD GENETICS INC., Form 8-K, filed with the SEC on 2025-06-05 — read the filing on EDGAR.

How asset managers voted at the MYRIAD GENETICS INC. 2024-2025 meeting

Each item below shows how the 250 asset managers that disclosed a MYRIAD GENETICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of MYRIAD GENETICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 67,755,156AGAINST: 5,847,659

MYRIAD GENETICS INC.’s own tally for this item (“Proposal 3: Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers, as Disclosed in the Proxy Statement”): 67,755,156 for, 5,847,659 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 92,200,000 outstanding shares: 73% for, 6% against (80% of the company cast a for/against vote).

The 246 asset managers below cast 93% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 93%

FOR: 92.9%AGAINST: 7.0%ABSTAIN: 0.1%NOT VOTED: 0.1%

Largest asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY ” at MYRIAD GENETICS INC., 2024-2025
Asset manager	For	Against	Vote
BlackRock	14,357,866	1,340	For
Vanguard	13,955,842	7,214	For
State Street	8,253,342	8,671	For
DISCIPLINED GROWTH INVESTORS INC /MN	0	4,023,596	Against
Wellington	3,792,509	0	For
GLENVIEW CAPITAL MANAGEMENT, LLC	3,720,518	0	For
EARNEST PARTNERS LLC	3,128,254	0	For
Fidelity	2,813,229	0	For
DE Shaw	2,402,588	0	For
Camber Capital Management LP	2,350,000	0	For
Charles Schwab	2,315,387	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,239,247	0	For
Dimensional	1,597,479	0	For
Invesco	1,542,252	0	For
Nuveen	1,081,085	0	For
TIAA	1,075,490	0	For
Northern Trust	694,106	0	For
MELLON INVESTMENTS Corp	622,067	0	For
Fisher Asset Management, LLC	577,214	0	For
Portolan Capital Management, LLC	564,709	0	For
Connor, Clark & Lunn Investment Management Ltd.	523,262	0	For
PRINCIPAL GLOBAL INVESTORS	452,847	0	For
JPMorgan	0	380,659	Against
Point72	372,108	0	For
Elevation Series Trust	0	346,279	Against

Showing the 25 largest of 246 asset managers. See all 246 in the interactive database.

2. Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Colleen F. Reitan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 69,922,952AGAINST: 3,732,650

MYRIAD GENETICS INC.’s own tally for this item (“Elect Director: Colleen F. Reitan”): 69,922,952 for, 3,732,650 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 92,200,000 outstanding shares: 76% for, 4% against (80% of the company cast a for/against vote).

The 67 asset managers below cast 95% of the shares they voted on this item FOR (35,853,262 for, 1,841,754 against).

FOR 95%

FOR: 35,853,262 (95.0%)AGAINST: 1,841,754 (4.9%)ABSTAIN: 0 (0.0%)NOT VOTED: 64,819 (0.2%)

Largest asset managers voting on “Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Colleen F. Reitan” at MYRIAD GENETICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	13,657,059	4,720	For
BlackRock	10,642,000	0	For
State Street	3,216,238	0	For
Fidelity	2,642,110	0	For
Dimensional	1,279,128	0	For
Charles Schwab	1,130,181	0	For
TIAA	0	1,075,090	Against
Invesco	0	656,247	Against
Elevation Series Trust	346,279	0	For
Goldman Sachs	253,198	0	For
Equitable	142,267	96,950	For
Jackson National	182,129	0	For
Columbia Threadneedle	180,059	0	For
JPMorgan	167,057	0	For
Global X	160,433	0	For
Prudential/PGIM	152,976	0	For
QUANTITATIVE MASTER SERIES LLC	150,778	0	For
Lincoln Financial	121,397	0	For
Northern Trust	111,886	0	For
BNY Mellon	98,811	0	For
Thrivent	93,170	0	For
Principal	88,419	0	For
TARGET PORTFOLIO TRUST	84,800	0	For
Voya	72,572	0	For
Direxion Shares ETF Trust	68,584	0	For

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

3. Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Heiner Dreismann, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 69,560,417AGAINST: 4,098,163

MYRIAD GENETICS INC.’s own tally for this item (“Elect Director: Heiner Dreismann, PH.D.”): 69,560,417 for, 4,098,163 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 92,200,000 outstanding shares: 75% for, 4% against (80% of the company cast a for/against vote).

The 67 asset managers below cast 99.6% of the shares they voted on this item FOR (37,580,503 for, 114,513 against).

FOR 99.5%

FOR: 37,580,503 (99.5%)AGAINST: 114,513 (0.3%)ABSTAIN: 0 (0.0%)NOT VOTED: 64,819 (0.2%)

Largest asset managers voting on “Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Heiner Dreismann,” at MYRIAD GENETICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	13,661,773	6	For
BlackRock	10,642,000	0	For
State Street	3,216,109	129	For
Fidelity	2,642,110	0	For
Dimensional	1,279,128	0	For
Charles Schwab	1,130,181	0	For
TIAA	1,075,090	0	For
Invesco	656,247	0	For
Elevation Series Trust	346,279	0	For
Goldman Sachs	253,198	0	For
Equitable	142,267	96,950	For
Jackson National	182,129	0	For
Columbia Threadneedle	180,059	0	For
JPMorgan	167,057	0	For
Global X	160,433	0	For
Prudential/PGIM	152,976	0	For
QUANTITATIVE MASTER SERIES LLC	150,778	0	For
Lincoln Financial	121,397	0	For
Northern Trust	111,886	0	For
BNY Mellon	98,811	0	For
Thrivent	93,170	0	For
Principal	88,419	0	For
TARGET PORTFOLIO TRUST	84,800	0	For
Voya	72,572	0	For
Direxion Shares ETF Trust	68,584	0	For

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

4. Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Samraat S. Raha

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 73,401,449AGAINST: 258,083

MYRIAD GENETICS INC.’s own tally for this item (“Elect Director: Samraat S. Raha”): 73,401,449 for, 258,083 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 92,200,000 outstanding shares: 80% for, 0.3% against (80% of the company cast a for/against vote).

The 67 asset managers below cast 99.9% of the shares they voted on this item FOR (37,695,016 for, 0 against).

FOR 99.8%

FOR: 37,695,016 (99.8%)AGAINST: 0 (0.0%)ABSTAIN: 0 (0.0%)NOT VOTED: 64,819 (0.2%)

Largest asset managers voting on “Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Samraat S. Raha” at MYRIAD GENETICS INC., 2024-2025
Asset manager	For	Vote
Vanguard	13,661,779	For
BlackRock	10,642,000	For
State Street	3,216,238	For
Fidelity	2,642,110	For
Dimensional	1,279,128	For
Charles Schwab	1,130,181	For
TIAA	1,075,090	For
Invesco	656,247	For
Elevation Series Trust	346,279	For
Goldman Sachs	253,198	For
Equitable	239,217	For
Jackson National	182,129	For
Columbia Threadneedle	180,059	For
JPMorgan	167,057	For
Global X	160,433	For
Prudential/PGIM	152,976	For
QUANTITATIVE MASTER SERIES LLC	150,778	For
Lincoln Financial	121,397	For
Northern Trust	111,886	For
BNY Mellon	98,811	For
Thrivent	93,170	For
Principal	88,419	For
TARGET PORTFOLIO TRUST	84,800	For
Voya	72,572	For
Direxion Shares ETF Trust	68,584	For

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

5. TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 78,614,062AGAINST: 3,591,463

MYRIAD GENETICS INC.’s own tally for this item (“Proposal 2: Ratification of the Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025”): 78,614,062 for, 3,591,463 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 92,200,000 outstanding shares: 85% for, 4% against (89% of the company cast a for/against vote).

The 67 asset managers below cast 99.9% of the shares they voted on this item FOR (37,694,881 for, 135 against).

FOR 99.8%

FOR: 37,694,881 (99.8%)AGAINST: 135 (0.0%)ABSTAIN: 0 (0.0%)NOT VOTED: 64,819 (0.2%)

Largest asset managers voting on “TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISC” at MYRIAD GENETICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	13,661,773	6	For
BlackRock	10,642,000	0	For
State Street	3,216,109	129	For
Fidelity	2,642,110	0	For
Dimensional	1,279,128	0	For
Charles Schwab	1,130,181	0	For
TIAA	1,075,090	0	For
Invesco	656,247	0	For
Elevation Series Trust	346,279	0	For
Goldman Sachs	253,198	0	For
Equitable	239,217	0	For
Jackson National	182,129	0	For
Columbia Threadneedle	180,059	0	For
JPMorgan	167,057	0	For
Global X	160,433	0	For
Prudential/PGIM	152,976	0	For
QUANTITATIVE MASTER SERIES LLC	150,778	0	For
Lincoln Financial	121,397	0	For
Northern Trust	111,886	0	For
BNY Mellon	98,811	0	For
Thrivent	93,170	0	For
Principal	88,419	0	For
TARGET PORTFOLIO TRUST	84,800	0	For
Voya	72,572	0	For
Direxion Shares ETF Trust	68,584	0	For

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

6. TO APPROVE THE PROPOSED AMENDMENT TO THE 2017 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMENDED, TO REPLENISH THE SHARE POOL FOR EQUITY INCENTIVE GRANTS.

COMPENSATIONMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 69,476,724AGAINST: 4,175,785

MYRIAD GENETICS INC.’s own tally for this item (“Proposal 4: Approval of a Proposed Amendment to the 2017 Plan to Replenish the Share Pool for Equity Incentive Grants”): 69,476,724 for, 4,175,785 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 92,200,000 outstanding shares: 75% for, 5% against (80% of the company cast a for/against vote).

The 66 asset managers below cast 99.6% of the shares they voted on this item FOR (37,572,061 for, 123,145 against).

FOR 99.6%

FOR: 37,572,061 (99.7%)AGAINST: 123,145 (0.3%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “TO APPROVE THE PROPOSED AMENDMENT TO THE 2017 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMEN” at MYRIAD GENETICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	13,661,773	6	For
BlackRock	10,642,000	0	For
State Street	3,216,109	129	For
Fidelity	2,642,110	0	For
Dimensional	1,279,128	0	For
Charles Schwab	1,130,181	0	For
TIAA	1,075,090	0	For
Invesco	656,247	0	For
Elevation Series Trust	346,279	0	For
Goldman Sachs	253,198	0	For
Equitable	239,217	0	For
Jackson National	182,129	0	For
Columbia Threadneedle	180,059	0	For
JPMorgan	167,057	0	For
Global X	160,433	0	For
Prudential/PGIM	94,002	58,974	For
QUANTITATIVE MASTER SERIES LLC	150,778	0	For
Lincoln Financial	121,397	0	For
Northern Trust	111,886	0	For
BNY Mellon	98,811	0	For
Thrivent	93,170	0	For
Principal	88,419	0	For
TARGET PORTFOLIO TRUST	84,800	0	For
Voya	72,572	0	For
Direxion Shares ETF Trust	68,584	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

7. Amend Restricted Stock Plan

COMPENSATIONMajority of the votes cast: yes

94% Majority: yes · of votes cast

FOR 94%

FOR: 69,476,724AGAINST: 4,175,785

The 3 asset managers below cast 0.9% of the shares they voted on this item FOR (71 for, 7,900 against).

11%NOT VOTED 89%

FOR: 71 (0.1%)AGAINST: 7,900 (10.9%)NOT VOTED: 64,819 (89.0%)

Largest asset managers voting on “Amend Restricted Stock Plan” at MYRIAD GENETICS INC., 2024-2025
Asset manager	For	Against	Vote
Empower	0	0	Not Voted
CLEARWATER INVESTMENT TRUST	0	7,900	Against
UNIFIED SERIES TRUST	71	0	For

8. SECTION 14A SAY-ON-PAY VOTES

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (564 for, 0 against).

FOR: 564 (100.0%)

Largest asset managers voting on “SECTION 14A SAY-ON-PAY VOTES” at MYRIAD GENETICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Members Trust Co	464	0	0	0	For
SWEENEY & MICHEL, LLC	100	0	0	0	For

Largest MYRIAD GENETICS INC. shareholders voting in 2024-2025

Ranked by the number of MYRIAD GENETICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 92,200,000 shares outstanding at the time of that meeting.

Top MYRIAD GENETICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	BlackRock	15.57%
2	Vanguard	15.14%
3	State Street	8.96%
4	DISCIPLINED GROWTH INVESTORS INC /MN	4.36%
5	Wellington	4.11%
6	GLENVIEW CAPITAL MANAGEMENT, LLC	4.04%
7	EARNEST PARTNERS LLC	3.39%
8	Fidelity	3.05%
9	DE Shaw	2.61%
10	Camber Capital Management LP	2.55%

Reported MYRIAD GENETICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

MYRIAD GENETICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	16.77%	13F
Vanguard Group	11.57%	13F
State Street	5.71%	13F
GLENVIEW CAPITAL MANAGEMENT, LLC	5.36%	13G
Wellington Management	4.98%	13F
Millennium Management	4.50%	13F
Barclays PLC	4.27%	13G
D.E. Shaw	2.74%	13F
Dimensional Fund Advisors	2.40%	13F
Morgan Stanley	1.75%	13F

Percentages above are of 92,200,000 shares outstanding, as reported by MYRIAD GENETICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MYRIAD GENETICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At MYRIAD GENETICS INC.'s shareholder meeting held 2025-06-05, in the 2024-2025 proxy season, 250 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,743 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS… — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: MYRIAD GENETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-05.

MYRIAD GENETICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.